本月全球药品研发进展取得成效的药物共有51个,较上月增加3个。进入注册阶段的有26个,较上月减少4个。其中,6个为全球首次注册的药品,在新市场补充注册的为20个。进入注册前阶段的有8个,较上月减少1个。进入Ⅲ期临床研究阶段的有17个,较上月大幅增加10个。其中,抗肿瘤药以16个高居榜首。抗感染药6个,位列次席。皮肤科用药有4个,名列第三。本月生物技术药物 There were 51 drugs that made progress in global drug development this month, up 3 from the previous month. There were 26 registrations, down 4 from the previous month. Among them, 6 are the first drugs registered in the world and 20 are newly registered in the new market. There were eight before entering the registration phase, a decrease from the previous month. There were 17 clinical trials entering stage III, a sharp increase of 10 from the previous month. Among them, anti-cancer drugs to 16 topped the list. Anti-infectives 6, ranked second place. Dermatological medication has 4, ranked third. This month biotech drugs